ARCA biopharma Inc (ABIO)
3.47
+0.10
(+2.91%)
USD |
NASDAQ |
May 10, 16:00
3.47
0.00 (0.00%)
After-Hours: 19:01
ARCA biopharma Enterprise Value: 13.01M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 13.01M |
| May 08, 2024 | 12.84M |
| May 07, 2024 | 11.83M |
| May 06, 2024 | 10.81M |
| May 03, 2024 | 11.39M |
| May 02, 2024 | 11.39M |
| May 01, 2024 | 11.25M |
| April 30, 2024 | 14.73M |
| April 29, 2024 | 13.86M |
| April 26, 2024 | 16.03M |
| April 25, 2024 | 14.58M |
| April 24, 2024 | 16.76M |
| April 23, 2024 | 17.03M |
| April 22, 2024 | 14.13M |
| April 19, 2024 | 13.40M |
| April 18, 2024 | 11.23M |
| April 17, 2024 | 10.65M |
| April 16, 2024 | 11.52M |
| April 15, 2024 | 10.21M |
| April 12, 2024 | 10.94M |
| April 11, 2024 | 11.23M |
| April 10, 2024 | 9.630M |
| April 09, 2024 | 9.485M |
| April 08, 2024 | 7.600M |
| April 05, 2024 | 8.905M |
| Date | Value |
|---|---|
| April 04, 2024 | 8.760M |
| April 03, 2024 | 11.23M |
| April 02, 2024 | -11.11M |
| April 01, 2024 | -10.53M |
| March 28, 2024 | -11.91M |
| March 27, 2024 | -12.05M |
| March 26, 2024 | -12.63M |
| March 25, 2024 | -12.34M |
| March 22, 2024 | -11.76M |
| March 21, 2024 | -11.62M |
| March 20, 2024 | -12.05M |
| March 19, 2024 | -12.20M |
| March 18, 2024 | -12.49M |
| March 15, 2024 | -12.92M |
| March 14, 2024 | -12.78M |
| March 13, 2024 | -12.92M |
| March 12, 2024 | -13.36M |
| March 11, 2024 | -13.58M |
| March 08, 2024 | -13.65M |
| March 07, 2024 | -13.79M |
| March 06, 2024 | -13.36M |
| March 05, 2024 | -13.21M |
| March 04, 2024 | -13.07M |
| March 01, 2024 | -13.21M |
| February 29, 2024 | -13.50M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-27.85M
Minimum
Jan 28 2022
30.30M
Maximum
Jul 31 2020
-8.348M
Average
-11.13M
Median
Jul 07 2022
Enterprise Value Benchmarks
| Shockwave Medical Inc | 12.12B |
| Asensus Surgical Inc | 50.19M |
| Kintara Therapeutics Inc | 15.45M |
| Glaukos Corp | 5.431B |
| Helius Medical Technologies Inc | -3.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.009M |
| Total Expenses (Quarterly) | 2.482M |
| EPS Diluted (Quarterly) | -0.14 |
| Earnings Yield | -12.10% |